Hemostasis And Thrombosis Research Society Inc
- Assets
- $4.1m
- Revenue
- $2.7m
- Investments
- $0.0
- Employees
- 0
- Location
- Milwaukee, WI
- Founding
- 09/1994
- Data as of
- 12/2023
- EIN
- 39-1796672
Organization Overview
Hemostasis And Thrombosis Research Society Inc is located in Milwaukee, WI. The organization was established in 1994. According to its NTEE Classification (Z99) the organization is classified as: Unknown, under the broad grouping of Unknown and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Hemostasis And Thrombosis Research Society Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Hemostasis And Thrombosis Research Society Inc generated $2.7m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 3.0% each year. All expenses for the organization totaled $2.5m during the year ending 12/2023. While expenses have increased by 5.6% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Hemostasis And Thrombosis Research Society Inc has awarded 125 individual grants totaling $8,678,742. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO BE THE LEADING NONPROFIT PROFESSIONAL SOCIETY IN NORTH AMERICA DEDICATED TO RESEARCH, MENTORING, WORKFORCE DEVELOPMENT, AND CONTINUING MEDICAL EDUCATION FOR PHYSICIANS, INVESTIGATORS, AND ALLIED HEALTH PROFESSIONALS INTERESTED IN ADVANCING CARE FOR PEOPLE WITH HEMOSTATIC AND THROMBOTIC DISORDERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CONTINUING PROFESSIONAL EDUCATION: HTRS OFFERED THE FOLLOWING PROGRAMS IN 2023 TO SUPPORT THE PROFESSIONAL EDUCATION AND CAREER DEVELOPMENT OF OUR MEMBERS: TWO (2) 1.5-DAY TRAINEE WORKSHOPS FOR MEDICAL RESIDENTS AND FELLOWS LAUNCHING CAREERS IN HEMOSTASIS AND THROMBOSIS; TWO (2) IN-PERSON CONECCTOR MEETINGS FOR THE HTRS JUNIOR FACULTY NETWORK HELD DURING NATIONAL MEETINGS; TWO (2) "BEST OF" EVENTS FOR ABSTRACT DISCUSSION AND NETWORKING EVENT HELD DURING NATIONAL MEETINGS; FOUR (4) FELLOWS NETWORK-CASE EXCHANGE SERIES VIRTUAL MEETINGS; ONE (1) SCIENTIFIC SYMPOSIUM, WHICH IS HTRS'S LARGEST EDUCATION AND CAREER DEVELOPMENT CONFERENCE, HELD OVER A THREE-DAY PERIOD; AND ONE (1) SEARCH WORKSHOP FOR UNDERGRADUATE, MEDICAL, AND DOCTORAL STUDENTS EXPLORING CAREERS IN HEMOSTASIS AND THROMBOSIS.
GRANTS AND ASSISTANCE: THE PRIMARY STRATEGIC OBJECTIVE OF HTRS IS TO COMBAT THE CRITICAL SHORTAGE OF SKILLED PHYSICIAN-SCIENTISTS AND DISCOVERY-BASED RESEARCHERS DEDICATED TO CAREERS IN HEMOSTASIS AND THROMBOSIS IN NORTH AMERICA. HTRS PROVIDES MEMBERS WITH OPPORTUNITIES TO APPLY FOR INVESTIGATOR-INITIATED RESEARCH GRANTS USING FUNDS RAISED FOR THIS PURPOSE FROM PHARMACEUTICAL COMPANIES VIA INDEPENDENT MEDICAL EDUCATION (IME) GRANTS OR CORPORATE SPONSORSHIP. HTRS AWARDS ARE DESIGNED TO SUPPORT MEMBERS AT CRITICAL STAGES OF THEIR CAREERS. THE STUDENT RESEARCH AWARD IS AN 8-WEEK INTRODUCTION TO BASIC OR TRANSLATIONAL RESEARCH IN NONMALIGNANT HEMATOLOGY FOR UNDERGRADUATE, MEDICAL, OR DOCTORAL STUDENTS WORKING WITH AN EXPERIENCED MENTOR. THE CLINICAL SCHOLAR AWARD PROVIDES FUNDING FOR A FOURTH AND FINAL YEAR OF INTENSIVE CLINICAL TRAINING IN HEMOPHILIA AND RARE BLEEDING DISORDERS. THE MENTORED RESEARCH AWARD IS DESIGNED TO PREPARE RECIPIENTS TO APPLY FOR A K-AWARD OR EQUIVALENT FROM THE NATIONAL INSTITUTES OF HEALTH (NIH) TO FORMALLY LAUNCH THEIR RESEARCH CAREERS IN ACADEMIC MEDICINE. THE MID-CAREER RESEARCH AWARD IS FOR SEASONED INVESTIGATORS WHO HAVE COMPLETED FELLOWSHIP AND/OR POSTDOCTORAL WORK BUT NEED SUPPORT TO TRANSITION FROM MENTORED RESEARCH TO FULLY INDEPENDENT, INVESTIGATOR-INITIATED RESEARCH. THE HTRS SEED GRANT INITIATIVE PROVIDES SMALL GRANTS FOR PHDS WHO NEED ADDITIONAL FUNDS TO GET THEIR PROJECTS READY TO COMPETE NATIONALLY FOR LARGER GRANT FUNDS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Shannon Carpenter MD Ms Immediate Past President | OfficerTrustee | 3 | $0 |
Shannon Meeks MD MBA President | OfficerTrustee | 3 | $0 |
Jordan Shavit MD PHD Vice President/president Elect | OfficerTrustee | 3 | $0 |
Lynn Malec MD Msc Treasurer | OfficerTrustee | 3 | $0 |
Arash Mahajerin MD Mscr Education Officer | OfficerTrustee | 3 | $0 |
Bryce Kerlin MD Research & Awards Officer | OfficerTrustee | 3 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Daniella Barsuglia Event Manager | 12/30/23 | $110,676 |
Versiti Wisconsin Inc Professional Employer Organization | 12/30/23 | $272,890 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $2,010,156 |
| Noncash contributions included in lines 1a–1f | $500 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,010,156 |
| Total Program Service Revenue | $571,170 |
| Investment income | $84,173 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $1,767 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $2,668,617 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $964,549 |
| Grants and other assistance to domestic individuals. | $15,000 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $146,690 |
| Compensation of current officers, directors, key employees. | $74,682 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $87,078 |
| Pension plan accruals and contributions | $6,303 |
| Other employee benefits | $16,711 |
| Payroll taxes | $16,106 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $101,760 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $9,497 |
| Fees for services: Other | $210,255 |
| Advertising and promotion | $181 |
| Office expenses | $27,811 |
| Information technology | $12,217 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $5,993 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $863,919 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $16,900 |
| All other expenses | $8,171 |
| Total functional expenses | $2,549,675 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $414,054 |
| Savings and temporary cash investments | $1,495,536 |
| Pledges and grants receivable | $579,744 |
| Accounts receivable, net | $9,019 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $79,432 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $1,535,819 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $4,113,604 |
| Accounts payable and accrued expenses | $123,292 |
| Grants payable | $0 |
| Deferred revenue | $78,573 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $201,865 |
| Net assets without donor restrictions | $2,563,377 |
| Net assets with donor restrictions | $1,348,362 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,113,604 |
Grants Awarded
Over the last fiscal year, Hemostasis And Thrombosis Research Society Inc has awarded $913,351 in support to 16 organizations.
| Grant Recipient | Amount |
|---|---|
BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SYSTEM PURPOSE: RESEARCH | $59,800 |
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL FOUNDATION INC PURPOSE: RESEARCH | $66,000 |
BAYLOR COLLEGE OF MEDICINE PURPOSE: RESEARCH | $16,200 |
REGENTS OF THE UNIVERSITY OF MICHIGAN PURPOSE: RESEARCH | $132,000 |
BETH ISRAEL DEACONESS MEDICAL CENTER INC PURPOSE: RESEARCH | $82,500 |
THE CHILDREN'S HOSPITAL OF PHILADELPHIA PURPOSE: RESEARCH | $174,551 |